PANOBINOSTAT for Neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 8 adverse event reports in the FDA FAERS database where PANOBINOSTAT was used for Neoplasm malignant.
Most Reported Side Effects for PANOBINOSTAT
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Diarrhoea | 368 | 20.2% | 76 | 124 |
| Plasma cell myeloma | 279 | 15.3% | 170 | 80 |
| Platelet count decreased | 192 | 10.6% | 72 | 90 |
| Death | 190 | 10.4% | 189 | 17 |
| Malignant neoplasm progression | 166 | 9.1% | 104 | 61 |
| Fatigue | 162 | 8.9% | 28 | 46 |
| Nausea | 154 | 8.5% | 44 | 63 |
| Thrombocytopenia | 141 | 7.8% | 30 | 60 |
| Off label use | 112 | 6.2% | 37 | 9 |
| Vomiting | 109 | 6.0% | 20 | 60 |
| Drug ineffective | 105 | 5.8% | 46 | 18 |
| Pneumonia | 99 | 5.4% | 39 | 69 |
| Pyrexia | 98 | 5.4% | 40 | 65 |
| Anaemia | 95 | 5.2% | 39 | 49 |
| White blood cell count decreased | 83 | 4.6% | 35 | 49 |
Other Indications for PANOBINOSTAT
Plasma cell myeloma (1,262)
Product used for unknown indication (244)
Plasma cell myeloma refractory (49)
Acute myeloid leukaemia (33)
Brain stem glioma (15)
Plasmacytoma (14)
Hodgkin's disease (13)
Plasma cell leukaemia (12)
Glioma (10)
Graft versus host disease (10)
Other Drugs Used for Neoplasm malignant
PALBOCICLIB (1,996)
CAPECITABINE (1,493)
PEMBROLIZUMAB (1,135)
PACLITAXEL (984)
CARBOPLATIN (977)
NIVOLUMAB (947)
OXALIPLATIN (823)
PAZOPANIB (716)
CYCLOPHOSPHAMIDE (685)
FLUOROURACIL (676)